February 17, 2024
Quality/Regulations
48
2
Steffen Thirstrup, chief medical officer at the European Medicines Agency, provides insight on regulatory challenges in Europe.
February 03, 2024
Cover Story
48
2
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
February 03, 2024
Peer-Reviewed
48
2
This article introduces that the basic technique for tolerance interval is implemented using the conventional range 85–115% LC where the proposed range in the PF is not taken into account.
February 03, 2024
Development
48
2
Continuous manufacturing and a quality-by-design development approach are a natural fit.
February 03, 2024
Manufacturing
48
2
Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.
February 02, 2024
Analytics
48
2
Effective analytics will eliminate failures, deviations, and non-conformances.
February 02, 2024
Outsourcing
48
2
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
February 02, 2024
Regulatory Watch
48
2
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
February 02, 2024
From The Editor
48
2
The industry’s M&A activity is on the up and expected to continue to rise in 2024.
February 02, 2024
From the CEO
48
2
Given its positioning at each new year’s commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed.
February 02, 2024
Ask the Expert
48
2
Validating computerized systems is required to demonstrate adherence to data integrity, says Susan J. Schniepp, distinguished fellow at Nelson Laboratories, LLC.
February 02, 2024
Product Spotlight
48
2
Designed for processing high viscosity dispersions and suspensions, the ROSS line of Dual-Shaft Mixers are versatile systems utilized in the chemical, pharmaceutical, food, cosmetic, adhesive, coating, composite, and other industries.
February 02, 2024
Product Spotlight
48
2
Distek’s software update for the Opt-Diss–In-Situ Fiber Optic UV System for Dissolution Testing, Version 3.20, introduces enhancements designed to streamline the dissolution testing process and expand the system’s capabilities.